Search

everythinglearnresearchcommunity

for

Search:↓

Too much AKR1C3 enzyme causes resistance to finasteride by increasing testosterone.

Plerixafor may help treat pigmentation disorders by promoting skin repigmentation.

Ritlecitinib is generally safe for alopecia areata patients over 72 months.

Derinat helps extend hair growth by reducing harmful molecules in skin cells.

Tofacitinib is more effective than methotrexate for treating moderate-to-severe alopecia areata.

Ritlecitinib effectively reduces severe hair loss in alopecia areata over 24 months.

Dutasteride is a safe and effective treatment for hair loss.

Baricitinib is effective and safe for severe alopecia areata, working similarly with or without an atopic background.

Dutasteride effectively treats enlarged prostate with manageable side effects.

The treatment combination is effective and generally safe for lung cancer.

Scalp microinfusion with dutasteride is a safe and promising treatment for male hair loss.

BAY 43-9006 helps control kidney cancer growth but doesn't significantly increase overall survival.

LX-38 is a safer drug option for treating prostate issues and hair loss without hormonal side effects.

Oral tofacitinib effectively treats alopecia areata long-term with manageable side effects.

LDE225 is a promising skin-applied treatment for basal cell carcinoma with good skin penetration and effectiveness.

Abrocitinib may help treat alopecia areata effectively with mild side effects.

Baricitinib helps grow eyebrows and eyelashes in severe alopecia areata patients.

Upadacitinib improved Crohn's disease, atopic dermatitis, and alopecia areata in one patient.

The FDA rejected a testosterone drug again due to safety concerns.

The new delivery method for dutasteride is more effective and has fewer side effects.

A reliable method was developed to measure aristolochic acid-I in rat blood.

The combination therapy is effective and well-tolerated for treating esophageal cancer.

Modified steroidal inhibitors showed promise in treating hormone-dependent cancers.

Using mirabegron and solifenacin together is safe and more effective for treating overactive bladder than using either drug alone.

Clascoterone is safe for the heart, even at high doses.

Tofacitinib works well for treating alopecia areata, especially when combined with corticosteroids, but is less effective if the disease has lasted over 2 years.

LY191704 is a compound that effectively blocks a specific enzyme involved in hormone conversion and could help treat enlarged prostate and hair loss.

LX-38 is a safer drug option for hair loss and prostate issues without hormonal side effects.